In a significant development for the dermatological sector, Glenmark Pharmaceuticals and Ireland-based Cosmo Pharmaceuticals have received the green light from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi, a topical solution for acne vulgaris, in the UK.
About the Author
